Chinese PE Firm HOPU, Bill Gates Invest In Long-Acting Drug Designer Lyndra

For Digital Subscribers Only

American drug delivery system developer Lyndra Therapeutics has raised US$55 million in a series B round of financing from Chinese private equity firm HOPU Investments and the Bill & Melinda Gates Foundation, according to an announcement yesterday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in


RELATED NEWS



LEAVE A REPLY